Elizabeth Snarr, PHARM D | |
789 Central Ave, Dover, NH 03820-2526 | |
(603) 609-6408 | |
Not Available |
Full Name | Elizabeth Snarr |
---|---|
Gender | Female |
Speciality | Pharmacist - Oncology |
Location | 789 Central Ave, Dover, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215646021 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835X0200X | Pharmacist - Oncology | 3530 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Elizabeth Snarr, PHARM D 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 609-6408 | Elizabeth Snarr, PHARM D 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 609-6408 |
News Archive
Among patients undergoing aortic valve replacement using a catheter tube, a comparison of two types of heart valve technologies, balloon-expandable or self-expandable valve systems, found a greater rate of device success with the balloon-expandable valve, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions.
Since the early 1900s, scientists have been wondering how birds and mammals could have developed almost identical conduction systems independently of each other when their common ancestor was a cold-blooded reptile with a sponge-like inner heart that has virtually no conduction bundles.
Push-ups, crunches, gyms, personal trainers - people have many strategies for building bigger muscles and stronger bones. But what can one do to build a bigger brain?
Despite important progress in research and development (R&D) for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the 'fatal imbalance' between global disease burden and drug development for some of the world most devastating illnesses, said Doctors Without Borders/M-decins Sans Fronti-res (MSF) and the Drugs for Neglected Diseases initiative (DNDi), in an analysis to be presented today at an international conference aimed at spurring medical innovations for these diseases.
Awarepoint Corporation, the leading provider of real-time location system (RTLS) solutions for healthcare, announced today that it has secured $27 million in Series F financing. New investor Kleiner Perkins Caufield & Byers (KPCB) led the round of financing, which also included participation from new investor Top Tier Capital Partners, and existing investors Cardinal Partners, Venrock, and Jafco Ventures.
› Verified 3 days ago
Katherine Anne Lombard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30 Grapevine Dr, Dover, NH 03820 Phone: 603-749-2374 Fax: 603-749-2051 | |
Mollie Pettigrew, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 679 Central Ave, Dover, NH 03820 Phone: 603-742-5313 | |
John Zinka, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30 Grapevine Dr, Dover, NH 03820 Phone: 603-749-2374 | |
Cheryl Fratamico, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 833 Central Ave, Dover, NH 03820 Phone: 603-749-9363 | |
Dr. Sonya Anne Kara, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-740-2512 | |
Christine Ouellette Morrison, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 118 Central Ave, Dover, NH 03820 Phone: 603-742-3995 Fax: 603-742-8180 | |
Amanda Houle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 833 Central Ave, Dover, NH 03820 Phone: 603-749-9361 |